Melanoma Lymphoma Articles & Analysis: Older
1 articles found
IL-2, approved by the FDA and several European countries, is a potent cytokine that is known to boost the immune system in patients fighting cancers such as malignant melanoma, renal cell cancer, leukemias and lymphomas. "Our study highlights the importance of age as a factor when designing cell-based or pharmacological therapies for older patients, and it ...